| 1 |
Stuart JM. Editorial for the Special Issue: Bacterial Meningitis-Epidemiology and Vaccination. Microorganisms 2021;9:917. [PMID: 33923323 DOI: 10.3390/microorganisms9050917] [Reference Citation Analysis]
|
| 2 |
Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M, Regueira M, Lara CS, Corso A; Argentina Spn Working Group. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 2021:S0264-410X(21)01616-9. [PMID: 34920903 DOI: 10.1016/j.vaccine.2021.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Choe YJ, Han MS, Choi YY, Sohn YJ, Kim YK, Kim KM, Park JY, Kang HM, Yoon IA, Choi JH, Oh CE, Cho EY, Lee H, Choi EH. Trend change of nasopharyngeal colonization with Streptococcus pneumoniae and non-typeable Haemophilus influenzae in children attending daycare centres: nationwide population-based study, South Korea 2014 and 2019. Int J Infect Dis 2021;111:328-32. [PMID: 34508859 DOI: 10.1016/j.ijid.2021.08.065] [Reference Citation Analysis]
|
| 4 |
Marmaras N, Xirogianni A, Papandreou A, Petinaki E, Papaevangelou V, Tsolia M, Tzanakaki G. Pneumococcal Serotype Identification by Capsular Sequence Typing (CST): A Modified Novel Approach for Serotyping Directly in Clinical Samples. Diagnostics (Basel) 2021;11:2353. [PMID: 34943589 DOI: 10.3390/diagnostics11122353] [Reference Citation Analysis]
|
| 5 |
Chang B, Tamura K, Fujikura H, Watanabe H, Tanabe Y, Kuronuma K, Fujita J, Oshima K, Maruyama T, Abe S, Kasahara K, Nishi J, Kubota T, Kinjo Y, Serizawa Y, Shimbashi R, Fukusumi M, Shimada T, Sunagawa T, Suzuki M, Oishi K; Adult IPD Study Group. Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan. Sci Rep 2022;12:3066. [PMID: 35197497 DOI: 10.1038/s41598-022-06950-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Kurihara E, Takeshita K, Tanaka S, Takeuchi N, Ohkusu M, Hishiki H, Ishiwada N. Clinical and Bacteriological Analysis of Pediatric Pneumococcal Meningitis after 13-Valent Pneumococcal Conjugate Vaccine Introduction in Japan. Microbiol Spectr 2022;:e0182221. [PMID: 35357224 DOI: 10.1128/spectrum.01822-21] [Reference Citation Analysis]
|
| 7 |
Wasserman MD, Perdrizet J, Grant L, Hayford K, Singh S, Saharia P, Horn EK, Farkouh RA. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infect Dis Ther 2021;10:2701-20. [PMID: 34633639 DOI: 10.1007/s40121-021-00544-1] [Reference Citation Analysis]
|
| 8 |
Tamura K, Chang B, Shimbashi R, Watanabe H, Tanabe Y, Kuronuma K, Oshima K, Maruyama T, Fujita J, Abe S, Kasahara K, Nishi J, Kubota T, Kinjo Y, Fujikura H, Fukusumi M, Shimada T, Sunagawa T, Suzuki M, Yamamoto Y, Oishi K; Adult IPD Study Group. Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019. Vaccine 2022:S0264-410X(22)00502-3. [PMID: 35489986 DOI: 10.1016/j.vaccine.2022.04.062] [Reference Citation Analysis]
|
| 9 |
Steens A, Knol MJ, Freudenburg-de Graaf W, de Melker HE, van der Ende A, van Sorge NM. Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands. Microorganisms 2022;10:972. [DOI: 10.3390/microorganisms10050972] [Reference Citation Analysis]
|
